Vote Scores

Home / Companies / Pacific Biosciences of California, Inc.

Company · votes reported on Form N-PXPACB · SEC company no. 1299130

Pacific Biosciences of California, Inc.

How funds and institutional managers reported voting their shares, year to 30 June 2026

Filers reporting
260year to 30 June 2026
Against management on pay
42.1%102 of 242 reporting filers
Same, by reported shares
12.8%shares reported on Form N-PX
Meetings on file
3across 3 seasons
53.3% for39.0% against7.7% other42.1% against management259 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

260 Form N-PX filers reported votes at Pacific Biosciences of California, Inc. for the year to 30 June 2026, across one meeting.

On the advisory vote on executive pay, 102 of the 242 filers that reported a position voted against management (42.1%), 35.6 percentage points above the median company on this site (6.6%). By reported shares the figure is 12.8% (median 2.9%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 21 voted with management on pay and 15 voted against: DWS, Dimensional, American Century, Principal, Victory Capital, Nuveen and TIAA, ProShares and ProFunds and AllianceBernstein and others.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
3 Jun 2026year to 30 June 2026260442.1%
4 Jun 2025year to 30 June 2025276470.1%
18 Jun 2024year to 30 June 2024326711.3%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2026Pacific Biosciences of California, Inc.Median company
Reporting filers voting against management42.1%6.6%
Reported shares voted against management12.8%2.9%

Among filers reporting on Form N-PX. The median is over 3,799 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 3 Jun 2026: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-pay
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalAgainst *
State Street and SPDRFor
American CenturyAgainst *
InvescoAgainst *
EquitableAgainst *
Charles SchwabFor
Nuveen and TIAAAgainst *
ProShares and ProFundsAgainst *
John Hancock and ManulifeAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *
J.P. MorganFor
Goldman SachsFor
WisdomTreeFor
PGIM and PrudentialFor
Jackson National fundsSplit or no vote
Northern Trust and FlexSharesFor
SEIFor
T. Rowe PriceAgainst *
Lincoln FinancialFor
VoyaFor
Russell InvestmentsFor
NationwideFor
Victory CapitalAgainst *
Brighthouse FundsAgainst
Guggenheim and RydexAgainst *
Columbia ThreadneedleAgainst *
BNY MellonFor
PrincipalAgainst *
Pacific Life fundsFor
Global XFor
AllianceBernsteinAgainst *
DWSAgainst *
AllspringSplit or no vote
Neuberger BermanFor
American BeaconFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 202432611.3%1.5%
year to 30 June 202527770.1%40.4%
year to 30 June 202626042.1%12.8%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
DIRECTOR ELECTIONS1,87441.9%
SECTION 14A SAY-ON-PAY VOTES1,19026.6%
COMPENSATION4419.9%
AUDIT-RELATED4299.6%
CORPORATE GOVERNANCE3628.1%
SHAREHOLDER RIGHTS AND DEFENSES1794.0%

Questions

How did large funds vote at Pacific Biosciences of California, Inc.?

For the year to 30 June 2026, 242 Form N-PX filers reported a say-on-pay vote at Pacific Biosciences of California, Inc.; 102 voted against management (42.1%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at Pacific Biosciences of California, Inc.?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2026.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which Pacific Biosciences of California, Inc. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 23 Sep 2026; the median compares 3,799 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Pacific Biosciences of California, Inc., grouped by company. The name is the most common spelling among filers; the ticker and SEC company number come from the SEC company tickers file, matched on the exact name. Not verified by the SEC. Filings read through 23 Sep 2026; page built 26 Sep 2026.